Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $866.9 million.

  • Fresenius Medical Care AG's Free Cash Flow fell 3165.46% to $866.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 470.53%. This contributed to the annual value of $3.3 billion for FY2024, which is 751.86% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Free Cash Flow of $866.9 million as of Q3 2025, which was down 3165.46% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Fresenius Medical Care AG's Free Cash Flow registered a high of $1.4 billion during Q2 2021, and its lowest value of $278.1 million during Q1 2024.
  • Moreover, its 5-year median value for Free Cash Flow was $973.2 million (2023), whereas its average is $843.7 million.
  • Per our database at Business Quant, Fresenius Medical Care AG's Free Cash Flow crashed by 5165.49% in 2021 and then surged by 6288.25% in 2025.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Free Cash Flow stood at $1.1 billion in 2021, then dropped by 23.75% to $818.2 million in 2022, then increased by 25.97% to $1.0 billion in 2023, then grew by 10.41% to $1.1 billion in 2024, then fell by 23.82% to $866.9 million in 2025.
  • Its Free Cash Flow was $866.9 million in Q3 2025, compared to $1.0 billion in Q2 2025 and $320.8 million in Q1 2025.